recording an average of over 7 days of heart monitoring. Despite US FDA approval, the Zio Patch has met slow acceptance possibly due to reimbursement hurdles. Explanations for the slow acceptance ...

SmartCardia has received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring ...

SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...

A heart monitor developed by iRhythm has become the ... The wearable electrocardiogram (ECG) patch and associated software has been tested for its ability to detect atrial fibrillation (AF ...

IDTechEx forecasts that flexible electronics in cardiac monitoring, deployed in electronic skin patches and electronic textiles, will be a $2 billion market in the year 2030. Electronic Skin ...

Initial trials demonstrated its ability to detect abnormal heart rhythms, coughing, and even falls — key indicators that can ...

A new wearable "smart" sensor patch can detect health symptoms early ... The team created sensors that monitor cardiac ...

However, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation ...

system for outpatient cardiac monitoring. It includes the Zio AT patch, which records ECG data for up to 14 days, and a wireless gateway that transmits data to iRhythm's Zio ECG Utilization ...

Application error: a client-side exception has occurred (see the browser console for more information).